Thomas Hutschalik creates different heart cell types from stem cells and combines them together. By checking how their rhythm is influenced by, for example, immune cells, he tries to help improve patients’ treatments.
Treating Arterial Fibrillation with Anti-Infammatories: Breaking the Wall of Arrhythmia
Ncardia Services / Maastricht University
Thomas is pursuing a PhD at Ncardia Services B.V. and the University of Maastricht (The Netherlands) as part of the EU-funded PersonalizeAF network. Thomas is a biomedical engineering graduate with a Master of Science from the University of Tübingen (Germany). His professional experiences include working at the Fraunhofer Institute (IGB), developing Organ-on-a-chip devices, and supporting the implementation of digital health in the EU at the European Commission. Thomas’ international research experiences include stays at the University of Georgia (USA) and the Tokyo Institute of Technology (Japan), receiving scholarships at both institutions. He has won several state debate championships and was a finalist in the German finale of the ‘Jugend debattiert’ competition. His award-winning research is part of the ‘PersonalizeAF’ Project, where he develops innovative tools to personalise atrial fibrillation treatments by creating disease models with a focus on cardiac inflammation.